RNA Splicing in Cancer and Targeted Therapies-Reference-Cited by-同舟云学术

RNA Splicing in Cancer and Targeted Therapies

Published:2023-10-29 Issue:11 Volume:14 Page:2020
ISSN:2073-4425
Container-title:Genes
language:en
Short-container-title:Genes

Author:

Islam Md Rafikul¹²,Nagar Preeti¹²,Neetole Shegufta Tasneem¹,Wan Ledong³,Rahman Mohammad Alinoor¹²

Affiliation:

1. Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA

2. Winthrop P. Rockefeller Cancer Institute, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA

3. Cold Spring Harbor Laboratory, Cold Spring Harbor, NY 11724, USA

Abstract

Since the discovery of RNA splicing as a fundamental step to remove introns from pre-mRNA to produce mature mRNAs, substantial research in the past decades has highlighted RNA splicing as a critical mediator of gene expression and proteome diversity, also being important in many developmental and biological processes [...]

Funder

Edward P. Evans Foundation

Publisher

MDPI AG

Subject

Genetics (clinical),Genetics

Link

https://www.mdpi.com/2073-4425/14/11/2020/pdf

Reference8 articles.

1. RNA splicing dysregulation and the hallmarks of cancer;Bradley;Nat. Rev. Cancer,2023

2. SnapShot: Splicing Alterations in Cancer;Rahman;Cell,2020

3. Wan, L., Deng, M., and Zhang, H. (2022). SR Splicing Factors Promote Cancer via Multiple Regulatory Mechanisms. Genes, 13.

4. Piazzi, M., Bavelloni, A., Salucci, S., Faenza, I., and Blalock, W.L. (2023). Alternative Splicing, RNA Editing, and the Current Limits of Next Generation Sequencing. Genes, 14.

5. Xu, R.-Y., Ding, Z., Zhao, Q., Ke, T.-Y., Chen, S., Wang, X.-Y., Wang, Y.-Y., Sheng, M.-F., Wang, W., and Long, N. (2022). An Alternatively Spliced Variant of METTL3 Mediates Tumor Suppression in Hepatocellular Carcinoma. Genes, 13.